Disclosure about Fair Value of Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2015

Disclosure about Fair Value of Financial Instruments (Tables) [Abstract]

Carrying amounts and estimated fair values of financial instruments

The carrying amounts and estimated fair values of our financial instruments are as follows (in thousands):

		December 31, 2015				December 31, 2014
		Carrying		Fair		Carrying		Fair
		Amount		Value		Amount		Value
Financial Assets:
	Mortgage loans receivable	$	635,492	$	663,501	$	188,651	$	194,935
	Other real estate loans receivable		184,000		185,693		191,518		195,375
	Available-for-sale equity investments		22,779		22,779		-		-
	Cash and cash equivalents		360,908		360,908		473,726		473,726
	Foreign currency forward contracts		129,520		129,520		57,087		57,087
Financial Liabilities:
	Borrowings under unsecured lines of credit arrangements	$	835,000	$	835,000	$	-	$	-
	Senior unsecured notes		8,548,055		9,020,529		7,729,405		8,613,702
	Secured debt		3,509,142		3,678,564		2,963,186		3,053,067
	Foreign currency forward contracts		-		-		1,495		1,495
Redeemable OP unitholder interests		$	112,029	$	112,029	$	46,722	$	46,722

The Market approach utilized to measure fair value of financial assets and liabilities on recurring basis

	Fair Value Measurements as of December 31, 2015
	Total		Level 1		Level 2		Level 3
Available-for-sale equity investments(1)	$	22,779	$	22,779	$	-	$	-
Foreign currency forward contracts(2)		129,520		-		129,520		-
Redeemable OP unitholder interests		112,029		-		112,029		-
Totals	$	241,549	$	-	$	241,549	$	-
(1) Unrealized gain or losses on equity investments are recorded in accumulated other comprehensive income (loss) at each measurement date. During 2015, we recognized an other than temporary impairment charge of $35,648,000 on the Genesis Healthcare stock investment which was recorded through other expense. Also see Note 11 for details related to the gain on the derivative asset originally recognized.
(2) Please see Note 11 for additional information.